Clinical Trials · NCT00943956
Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Enrollment
- 30
- Start date
- Jan 2009
- Locations
- 1 site, France
- Primary endpoint
- Acute and late toxicities